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Receptor dimerization is ubiquitous to the action of all 
receptor tyrosine kinases, and in the case of dimeric 
ligands, such as the stem cell factor (SCF), it was attrib- 
uted to ligand bivalency. However, by using a dimer- 
ization-inhibitory monoclonal antibody to the SCF re- 
ceptor, we confined a putative dimerization site to the 
nonstandard fourth immunoglobulin-like domain of 
the receptor. Deletion of this domain not only abol- 
ished ligand-induced dimerization and completely in- 
hibited signal transduction, but also provided insights 
into the mechanism of the coupling of ligand binding 
to dimer formation. These results identify an intrinsic 
receptor dimerization site and suggest that similar 
sites may exist in other receptors. 
Introduction 
Receptor dimerization has been extensively studied in the 
family of transmembrane tyrosine kinases, the common 
catalytic activity of which is stimulated by binding of a 
ligand to the variable extracellular domain (UIIrich and 
Schlessinger, 1990). Almost invariably, all of the tyrosine 
kinase receptors transverse the pla:sma membrane only 
once, and their transmembrane stretches display no con- 
served structural motifs, except for high hydrophobicity. 
This raised the possibility that signal transduction may 
involve intermolecular ather than intramolecular interac- 
tions. Studies performed with an isolated receptor for the 
epidermal growth factor (EGF) supported this model as 
they demonstrated that ligand binding was followed by 
rapid, but reversible, dimerization of occupied receptors 
and a concomitant increase in autophosphorylation (Yar- 
den and Schlessinger, 1987). In living cells, EGF recep- 
tors, as well as the receptors for colony-stimulating factor 
1 (CSF-1) and platelet-derived growth factor (PDGF), un- 
dergo dimerization that can be demonstrated by the use 
of covalent cross-linking reagents (Bishayee et al., 1989; 
Cochet et al., 1988; Li and Stanley, 1991). 
An oligomerization activation model is indirectly sup- 
ported also by in vivo lines of evidence. For example, a 
carcinogen-induced point mutation within the single trans- 
membrane domain activates the tyrosine kinase function 
of the neu-encoded receptor and renders the protein onco- 
genic, probably through constitutive dimerization (Weiner 
et al., 1989). Likewise, heterodimer formation between 
highly homologous receptors, such as the EGF receptor 
and the Neu protein, and the (~ and 13 forms of the PDGF 
receptor is probably responsible for the observed in- 
creases in ligand binding affinities, tyrosine phosphoryla- 
tion, and biological activities (Goldman et al., 1990; Ham- 
macher et al., 1989; Wada et al., 1990). Lastly, the genetic 
phenomenon of dominance of certain mutant alleles of 
receptor tyrosine kinases in heterozygous animals is best 
explained by the formation of signaling-defective dimers 
comprised of wild-type and mutant receptors (Kashles et 
al., 1991; Nocka et al., 1990; Reith et al., 1990). 
Despite these in vitro and in vivo lines of evidence, the 
molecular mechanisms that underlie the process of recep- 
tor dimerization are still largely unknown. In the case of 
dimeric ligands, receptor dimerization has been attributed 
to bivalent ligand binding (Williams, 1989), but dimeriza- 
tion by monovalent ligands, such as EGF, may require 
alternative mechanisms. To address some of these open 
questions, we selected the system of the c-kit-encoded 
receptor and its cognate ligand, the stem cell factor (SCF). 
Natural rodent mutants of both SCF and its receptor are 
defective in gametogenesis, melanogenesis, and erythro- 
poiesis (Besmer, 1991). As expected, Kit undergoes ex- 
tensive dimerization upon binding of SCF (Blume-Jensen 
et al., 1991 ; Lev et al., 1992b). Dimer formation, however, 
appears to be independent of the bivalency of the dimeric 
ligand since no dissociation of the dimers was observed 
at a large excess of SCF. In addition, the human ligand 
promoted heterodimer formation between the human and 
the murine receptors, despite the lack of ligand binding 
to the rodent Kit (Lev et al., 1992b). These and other lines 
of evidence led us to propose that a receptor site, which 
is distinct from the ligand-binding pocket, stabilizes ligand- 
induced dimers of Kit (Lev et al., 1992b). The extracellular 
portio n of Kit/SCF receptor includes five immunoglobulin- 
like domains, of which the three N-terminal domains com- 
prise the ligand-binding site (Blechman et al., 1993; Lev 
et al., 1993), but the function of the fourth and fifth domains 
remained unknown. In an effort to localize the putative 
dimerization site, we constructed and expressed in mam- 
malian cells the whole extracellular domain of Kit. The 
soluble ectodomain not only bound SCF with high affinity 
but also underwent efficient dimerization (Lev et al., 
1992c). This implied that the putative dimerization site is 
confined to the extracellular portion of Kit. In the present 
study, we attempted to localize the hypothetical igand- 
dependent dimerization site by employing a monoclonal 
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Figure 1. Interaction ofMAbs with Monomers and Dimers of Kit 
(A) Monolayers of murine fibroblasts that overexpress human kit (ap- 
proximately 1 x 10 ~ cells) were incubated with radiolabeled SCF in 
the presence of the indicated concentrations of various MAbs to Kit. 
Following 2hr at 4°C, the cells were washed, and the ligand-receptor 
complexes were covalently cross-linked by a 40 min incubation at 
22°C with 15 mM EDAC. Cell lysates were then prepared and directly 
subjected to electrophoresis on 50/0 SDS-PAGE. Autoradiography of 
the dried gels was for 24 hr at -70°C with an intensifier screen. The 
locations of molecular mass marker proteins are indicated by bars, 
and the corresponding masses are given in kilodaltons. Receptor mo- 
nomers (M) and dimers (D) are indicated by arrows. 
(B) Covalent complexes of radiolabeled SCF and Kit were prepared 
in the absence of MAbs as described above. Cell lysates were then 
prepared and subjected to immunoprecipitation with the indicated 
MAbs to Kit. The immune complexes were analyzed by electrophoresis 
on 5% SDS-PAGE and autoradiography. 
of Kit. Using these molecular tools, we mapped the dimer- 
ization site to the fourth immunoglobulin-like domain of Kit. 
In addition, inhibition of receptor dimerization by means of 
a MAb or through the use of the domain 4-deleted receptor 
allowed us to determine the functional consequences of
the dimerization process and indicated that i is driven by 
a slower rate of release of the ligand from receptor dimers 
as compared with receptor monomers. 
Results 
An Anti-Kit MAb that Inhibits Receptor Dimerization 
We have previously reported that a recombinant whole 
extracellular domain of Kit fully retained two functions of 
the wild-type receptor: high affinity binding of SCF and 
ligand-induced receptor dimerization (Lev et al., 1992c). 
To identify the structures that undedie these two molecular 
functions of Kit, we raised a panel of MAbs by immunizing 
mice with the recombinant human ectodomain (denoted 
Kit-X). Whereas some MAbs completely inhibited SCF 
binding and thereby enabled immunological mapping of 
the ligand-binding site, other MAbs exerted only limited 
or no effect on ligand binding (Blechman et al., 1993). 
MAbs that belong to the latter group were therefore xam- 
ined in respect to their effect on ligand-dependent dimer- 
ization of Kit and their capacity to recognize receptor di- 
mers. Two MAbs, designated K27 and K69, were found 
to inhibit selectively cross-linking of radiolabeled SCF to 
the dimeric form of the receptor in living cells (Figure 1). 
The effect of MAb K27 was concentration dependent; an 
almost complete disappearance of the cross-linked dimer 
was observed upon coincubation of cells that overexpress 
Kit with a radiolabeled SCF and saturating concentrations 
of the MAb. In contrast with the effect of K27, antibody K44, 
which interacted with the ligand-binding site (Blechman et 
al., 1993), inhibited cross-linking of SCFto both monomers 
and dimers of Kit, whereas a third antibody, K45, displayed 
neither effect (Figure 1A). Other experiments hat are not 
presented here indicated that the effect of MAb K27 was 
independent of its bivalency because a monovalent frag- 
ment of the antibody (denoted Fab-K27) also inhibited 
cross-linking of SCF to receptor dimers. Consistent with 
the capacity of MAb K27 to selectively inhibit the formation 
of complexes between SCF and Kit dimers, this antibody 
was unable to recognize preformed dimeric complexes; 
whereas both monomeric and dimeric complexes of Kit 
and radiolabeled SCF were recognized by MAbs K45 and 
K49, only the monomeric Kit-SCF complex was immuno- 
precipitable by MAb K27 (Figure 1B). By contrast, MAbs 
that recognized the ligand-binding site (i.e., K44, K57, and 
K58) precipitated neither form of the receptor. Based on 
the results that are depicted in Figure 1, it was concluded 
that MAb K27 interacts with a site of Kit that is involved 
in receptor dimerization and the accessibility of which is 
masked within dimers of Kit. 
The Putative DimerizaUon Site Maps to the Fourth 
Immunoglobulin-like Domain of Kit 
The inability of the murine K27 antibody to recognize the 
routine Kit protein was exploited while attempting to con- 
fine the antigenic epitope of MAb K27 to 1 of the 5 immuno- 
globulin-like domains of Kit. A chimeric human Kit protein, 
whose three N-terminal immunoglobulin-like domains 
were replaced with the corresponding portion of the mu- 
rine receptor, has been previously described (Lev et al., 
1993) and has been denoted HM-123 (Figure 2a). This 
protein was recognized by MAb K27 (data not shown), 
indicating that the antibody recognized the fourth or the 
fifth immunoglobulin-like domain. To confine further the 
putative dimerization site to a single immunoglobulin-like 
domain, we utilized a series of soluble Kit proteins that 
were constructed by introducing stop codons distally to the 
second, third, and fourth immunoglobulin-like domains. 
These soluble proteins, designated Kit 1-2, Kit 1-2-3, and 
Kit 1-2-3-4, respectively (Figure 2a), were_expressed in 
Chinese hamster ovary (CHO) cells and were harvested 
from the respective conditioned media. Immunoprecipita- 
tion analysis indicated that a soluble protein that contained 
all of the four N-terminal immu noglobulin-like domains (Kit 
1-2-3-4) was recognized by MAb K27, but deletion of the 
fourth domain or both the third and the fourth structural 
units abolished interaction with the MAb (Figure 2b). A 
control MAb that interacted with the second immunoglobu- 
lin-like domain, namely K45, recognized all of the recombi- 
nant Kit proteins. To confirm mapping of the K27 epitope 
to the fourth immunoglobulin domain, we constructed a 
Kit Dimerization Site 
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Figure 2. Epitope Mapping ofMAb K27 by Using Mutant Kit Proteins 
(a) Schematic representations of recombinant soluble and transmembrane Kit proteins. The horizontal stippled box represents the plasma em- 
brane, and the vertical open boxes depict the tyrosine kinase portions. The immunoglobulin-like domains are shown by loops, which are marked 
1-5. The locations of all of the cysteine residues of the extracellular domain are indicated by a circle and C. Tryptophan residues that belong to 
the immunoglobulin homology unitare shown by a circle and W. The bold line in HM-123 indicates the portion of the chimeric protein that was 
derived from murine Kit. KI, kinase insert; wt, wild-type. 
(b) The indicated soluble portions of the extracellular domain of Kit were expressed in CHO cells and harvested from pS]methionine biosynthetically 
labeled supernatants by means of immunoprecipitation (IP)with K45 or K27 MAbs. Following gel electrophoresis, the labeled proteins were 
visualized by autoradiography for 48 hr at -70°C with an intensifier screen. M,, relative molecular weight. 
(c) Monolayers of 5 x 106 mouse fibroblasts hat overexpressed either the wild-type human Kit protein (wt) or a mutant that lacked the fourth 
immunoglobulin-like domain (A4) were incubated at 37°C for 16 hr with [~S]methionine i  methionine-free medium. Cell lysates were then prepared, 
and the Kit proteins were subjected to immunoprecipitation (IP)with the indicated MAbs orwith a rabbit antibody to theC-terminal tail of Kit (212). 
The washed immunocomplexes were resolved by gel electrophoresis. An autoradiogram of the dried gelis shown along with the locations of 
marker proteins. Mr, relative molecular weight. 
mutant of the transmembrane receptor that lacked this 
structure. The deletion mutant, denoted A4 (Figure 2a), 
was stably expressed in murine 3T3 fibroblasts. Although 
this protein was recognized by MAbs K44 and K45, the 
dimerization-inhibitory MAb K27 was unable to interact 
with it (Figure 2c). Taken together, the results shown in 
Figure 2 indicated that the fourth immunoglobulin-like do- 
main of Kit includes the antigenic site of MAb K27, which, 
by inference, functions as a Iigand-dependent dimeriza- 
tion site. 
Ligand-lnduced Dimerization of Soluble and 
Membrane Forms of Kit Depends on the Presence 
of the Fourth Immunoglobulin-like Domain 
We next examined the coincidence of the putative dimer- 
ization site of Kit with the epitope of MAb K27 by per- 
forming a dimerization assay of soluble Kit proteins. As 
reported previously (Lev et al., 1992c), incubation of the 
whole soluble ectodomain of Kit with SCF in the presence 
of a bifunctional covalent cross-linking reagent resulted 
in the appearance of receptor dimers in SDS-polyacryl- 
amide gel electrophoresis (SDS-PAGE) (Figure 3A). By 
contrast, under the same conditions, a truncation mutant 
that contained only the three N-terminal immunoglobulin- 
like domains underwent no SCF-dependent dimerization 
(Figure 3A). Consistent with the possibility that the fourth 
immunoglobulin-like domain contains a dimerization site, 
its presence conferred to a soluble Kit protein, which con- 
tained all of the four N-terminal immunoglobulin-like do- 
mains (namely, Kit 1-2-3-4), the abilityto undergo dimeriza- 
tion in the presence of SCF (Figure 3A). Dimerization 
assays that were performed with transmembrane forms 
of Kit and a radiolabeled SCF further supported the pos- 
sibility that the fourth immunoglobulin-like domain is nec- 
essary for SCF-induced receptor dimerization; unlike the 
full-length Kit protein that displayed both dimers and mo- 
nomers in the presence of SCF, only monomers of the A4 
mutant were observed in living cells (Figure 3B). Ligand 
binding to either protein could be abolished by MAb K44, 
but MAb K27 inhibited receptor dimerization with no effect 
on SCF binding to the monomeric forms of Kit (Figure 3B). 
To examine alternative xplanations for the inability of 
Kit 1-2-3 to form dimers (namely, differences in affinities 
for ligand binding or differences in the ability to become 
covalently linked by the cross-linker), we compared the 
binding affinities of Kit-X, Kit 1-2-3-4, and Kit 1-2-3 by using 
ligand displacement and Scatchard analyses, and we 
found that hey were very similar (KD = 1-2 nM; data not 
shown). In addition, the molecular weights of Kit-SCF 
complexes were determined in the absence of cross- 
linking reagent by using native gel electrophoresis (Ams- 
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Figure 3. Ligand-Dependent Dimerization of Recombinant Kit Pro- 
teins 
(A) Supernatants of CHO cells that expressed the indicated Kit proteins 
were incubated for 4 hr at 4°C with 5 nM SCF or with TGFa (7 nM) 
in a 0.06 ml volume. To cross-link receptor-ligand complexes, DSS 
was added to 0.5 mM final concentration, and incubation continued 
for an additional 40 min. Covalent complexes were then separated by 
SDS-PAGE and transferred onto nitrocellulose filters. The latter was 
immunoblotted with a poiyclonal rabbit antiserum to Kit-X. Note that 
the lowest band in each lane corresponds to the respective soluble 
Kit protein, whose monomeric complex with SCF (indicated by M) dis- 
played a slightly retarded mobility in comparison to uncomplexed Kit 
protein, whereas the dimeric forms (labeled D) migrated for shorter 
distances. IP Ab, immunoprecipitated antibody; Mr, relative molecular 
weight. 
(B) Mouse fibroblasts that overexpressed full-length human Kit (wt) or 
a mutant hat lacked the fourth immunoglobulin-like domain (44) were 
incubated for 2 hr at4°C with 2 nM 1251-SCF in the presence of 10 pg/ 
ml of the indicated MAb or with no antibody. The cross-linking reagent 
EDAC was then added to 15 mM final concentration, and the incubation 
was continued for 40 min at 22°C. Covalent complexes of radiolabeled 
upon the observation that increasing gel concentrations 
affect the migration of larger proteins more than smaller 
proteins. Kit-X and Kit 1-2-3 were incubated with radiola- 
beled SCF in the absence of a cross-linking reagent and 
were then resolved by electrophoresis through a series of 
gels that differed in their acrylamide concentrations (5%-  
9%; Figure 3C shows an example of a 8.5% gel). A func- 
tion of the relative mobility of each radio!abeled complex, 
as well as the mobilities of standard proteins, was then 
plotted versus the concentration of acrylamide to construct 
Ferguson plots (data not shown). The slope of each plot 
yielded a retardation coefficient the logarithm of which was 
then plotted against the logarithm of the relevant molecu- 
lar weight range (Figu re 3D). By extrapolation of their retar- 
dation coefficients, the native molecular weights of the 
two species of Kit-X were 130 kDa and 240 kDa, whereas 
the single Kit 1-2-3 species corresponded to 90 kDa (Fig- 
ure 3D). This analysis confirmed that Kit -X-SCF com- 
plexes exist as monomers and dimers in solution, but the 
respective complex of Kit 1-2-3 is present only in a mono- 
meric form. 
The Fourth Immunoglobulin-like Domain Enables 
Coupling of Ligand Binding to Kinase Activation 
The availabil ity of a dimerization-inhibitory MAb to Kit and 
a receptor mutant with defective dimerization enabled us 
to address the necessity of receptor dimerization for signal 
transduction. This question was first analyzed in relation 
to stimulation of the intrinsic tyrosine kinase activity of Kit. 
Preincubation of Kit-expressing cells with MAb K27, but 
not with other MAbs that do not affect receptor dimefiza- 
tion, inhibited tyrosine autophosphorylat ion of Kit (Figure 
4A). The effect was concentration dependent,  and it was 
displayed also by the dimerization-inhibitory monovalent  
fragment of MAb K27 (Figure 4B). Consistent with an inter- 
pretation that receptor dimerization is essential for kinase 
activation, SCF at concentrations as high as 500 ng/ml 
was unable to elevate tyrosine phosphorylation of the di- 
merization-defective mutant of Kit, namely A4. By con- 
trast, significant stimulation was observed in cells express- 
SCF and Kit proteins were then analyzed by immunoprecipitation with 
an anti-Kit-X rabbit antiserum, followed by SDS-PAGE (6% acryl- 
amide) and autoradiography. 
(C) Purified Kit-X (1 p~g) or Kit 1-2-3 (1 pg) was incubated for 2 hr at 
22°C with radiolabeled SCF in the presence (plus Sign) or absence 
(minus sign) of BS 3 (0.5 mM) and was then subjected to native gel 
electrophoresis (8.5% acrylamide) in the absence of SDS. The re- 
sulting autoradiogram is shown. 
(D) Determination of molecular weights. Ferguson plots were plotted 
for the following molecules on the basis of their mobilities on a set 
of native gels that contained various concentrations of acrylamide: 
ovalbumin (open triangle, 43 kDa), bovine serum albumin (open dia- 
mond, 67 kDa), lactate dehydrogenase (crossed lines, 140 kDa), cata- 
lase (closed triangle, 232 kDa), ferritin (closed diamond, 440 kDa), and 
thyroglobulin (closed square, 669 kDa). The coefficient of retardation of 
each molecule was deduced from the slopes, and their logarithms are 
presented as function of their molecular weights. The same analysis 
was performed for the two species of Kit-X and the single form of Kit 
1-2-3 (labeled by arrows). 
Abbreviations: D, dimeric form; kD, kilodaltons; M, monomeric form. 
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Figure 4. TheEffectoflnhibitionofReceptorDimerizationonTyrosine 
Autophosphorylation f Kit 
(A and B) Monolayers (approximately 5 x 106 cells) of CHO cells that 
overexpressed the human Kit protein were incubated for 40 min at 
4°C with the indicated MAbs or with a monovalent fragment of MAb 
K27 (Fab-K27). SCF (100 ng/ml) was then added to some of the mono- 
layers (labeled with a plus sign), and the incubation was continued 
for 10 min at 37°C. Cell lysates were then prepared in the presence 
of phosphatase inhibitors, and the Kit protein was subjected to immu- 
noprecipitation with a polyclonal rabbit antibody (IP Ab) to Kit-X. The 
immunocomplexes were resolved by gel electrophoresis and trans- 
ferred onto nitrocellulose filters that were blotted with a MAb to phos- 
photyrosine (PY20) and detected by chemiluminescence. The final 
concentrations of Fab-K27 and K44, unless indicated, were 5 #g/ml 
and 1 p.g/ml, respectively. Minus sign, o SCF added; Mr, relative 
molecular weight. 
(C) Murine fibroblasts that overexpressed fulNength Kit (wt) or a protein 
that lacked the fourth immunoglobulin-like domain (A4) was incubated 
for 10 min at 37°C in the absence (minus sign) or presence (plus 
sign) of SCF (100 ng/ml). Cell lysates were then prepared, and the 
Kit proteins were immunoprecipitated with an antibody (IP Ab) to the 
C-terminal tail (212). The immunocomplexes were resolved by gel elec- 
trophoresis, which was followed byimmunoblotting (IB) with either an 
antibody to phosphotyrosine (PY20 [ICN Biochemicals]) oran antibody 
to Kit (anti-Kit-X). 
ing the wild-type receptor (Figu re 4C). Control experiments 
that involved Western blotting (Figure 4C) and in vitro ki- 
nase assays (data not shown) excluded the possibility that 
the differential effect was due to loss of expression of A4 
or inactivation of its catalytic function, respectively. 
Receptor Dimerization Is Essential for Short- and 
Long-Term Effects of the SCF 
It was predictable that inhibition of kinase activation 
through interference with receptor dimerization will inhibit 
all downstream signaling events that are elicited by SCF. 
As a short-term effect, we selected the interaction of li- 
gand-stimulated Kit with the intracellular enzyme phos- 
phatidylinositol 3'-kinase (PI3K) (Lev et al., 1992a). Unlike 
the ligand-stimulated wild-type Kit that underwent coim- 
munoprecipitation with the lipid kinase, the dimerization- 
defective A4 protein was unable to undergo coupling to 
PI3K after stimulation with SCF. This was demonstrated 
by either an in vitro PI3K assay of receptor immunoprecipi- 
tates (Figure 5a) or by Western blotting with anti-PI3K anti- 
bodies (Figure 5b). We next investigated the ability of the 
dimerization-defective receptor mutant o induce a change 
in intracellular Ca 2+ concentration by using the Ca2+-sensi - 
tive fluorophor Fura2-AM. Dye-loaded cells that overex- 
pressed either wild-type Kit or &4 were incubated with 
SCF, and intracellular Ca 2+ concentrations were moni- 
tored. Whereas a rapid increase in Ca 2+ concentration that 
peaked at 10-15 s was observed in Kit-expressing cells, 
no change took place in A4-expressing cells (Figure 5c), 
even after longer incubation and with higher ligand con- 
centrations (up to 300 ng/ml; data not shown). For control, 
we incubated the serum-starved cells with fetal calf serum 
(5% FCS) and observed similar Ca 2+ mobilizations in both 
cell lines, indicating that they differed in the response to 
SCF but not in response to other factors. 
To demonstrate the requirement of receptor dimeriza- 
tion and tyrosine kinase activation for long-term actions 
of SCF, we used the dimerization-inhibitory MAb and the 
SCF-dependent myeloid cell line TF-I. The cells were first 
starved for serum factors and were then incubated with 
SCF in conditions under which the factor maintained their 
viability and proliferation. Coincubation of the cells with 
SCF and increasing concentrations of MAb K27 resulted 
in gradual inhibition of DNA synthesis, as measured by 
the incorporation of [3H-methyl]thymidine i to macromole- 
cules (Figure 6A). More extensive inhibition was induced 
bythe ligand-competitory MAb K44, which, like K27, inhib- 
ited receptor phosphorylation (see Figure 4A). Consistent 
with the necessity of receptor dimerization for the effect of 
SCF on cell cycle regulation, no increase in DNA synthesis 
was observed in SCF-stimulated murine fibroblasts that 
expressed the dimerization-defective A4 receptor (Figure 
6B). By contrast, fibroblasts that expressed the wild-type 
receptor displayed a bell-shaped dose-response curve. 
Taken together, the results depicted in Figures 5 and 6 
implied that receptor dimerization is essential for both 
short- and long-term biological effects of SCF. 
Inhibition of Receptor Dimerization Reduces 
SCF Binding Affinity by Accelerating 
Ligand Dissociation 
The relationships between ligand binding affinity and di- 
merization of receptor tyrosine kinases are presently un- 
clear. To address this question in the Kit-SCF system, we 
examined the effect of inhibition of receptor dimedzation 
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Figure 5. Dependency of Short-Term Biological Effects of SCF on Receptor Dimerization 
(a) Monolayers of murine fibroblasts (1 x 106 cells) that expressed either wild-type (wt) Kit or a mutant that lacked immunoglobulin domain 4 (A4) 
were incubated inthe absence (minus sign) or presence (plus sign) of SCF (100 ng/ml). After 10 min at 37°C, cell lysates were prepared, and 
the Kit protein was subjected to immunoprecipitation. Washed immunocomplexes were assayed in vitro for associated PI3K activity as described 
(Lev et al., 1992a), and the reaction products were separated using thin layer chromatography. Shown is an autoradiogram of a portion of the 
thin layer plate that corresponds to the location of phosphatidylinositol 3'-phosphate (PIP). Mr, relative molecular weight. 
(b) Cells were treated with SCF (absence of SCF, minus sign; addition of SCF, plus sign), and lysates were immunoprecipitated as in (A). The 
immunocomplexes were subjected to gel lectrophoresis, which was followed by Western blot analysis with an anti-PI3K antibody. The 85 kDa 
band corresponds to the regulatory subunit of PI3K, whereas the lower protein bands represent the heavy chain of the antibody used for immunoprcipi- 
tation. Mr, relative molecular weight. 
(c) Representative computerized images of factor-treated cells that expressed wild-type Kit protein (WT) or a domain 4-deleted mutant (A4). Fura2- 
AM-loaded cells were stimulated with SCF (100 ng/ml) or FCS (5%), or they were left untreated (CONTROL). Images were taken 12 s after 
stimulation. The pseudoimage colors represent increasing co centrations of Ca 2÷. The experiment was repeated three times. 
tion-defective receptor. Ligand saturation curves showed 
that both means of inhibition of receptor dimerization re- 
sulted in a significant reduction i SCF binding (Figures 
7A and 7C, see insets). Analysis of the binding data ac- 
cording to the method of Scatchard (Scatchard, 1949) re- 
vealed that this was due to a reduction in receptor affinity. 
Whereas treatment with the dimerization-inhibitory anti- 
body resulted in a linear Scatchard plot that indicated re- 
duced affinity and partial disappearance of binding sites 
(Figure 7A), the dimerization-defective receptor displayed 
a curvilinear Scatchard plot (Figure 7C). This may be due 
to negative cooperativity or to the existence of two receptor 
populations, a minor population (KD = 0.2 nM) and a major 
class, that corresponded to approximately 90% of the 
binding sites and affinity of which (KD -- 3.5 nM) was com- 
parable with that observed when receptor dimerization 
was inhibited by MAb K27. 
Ligand affinity is determined by the rates of ligand asso- 
ciation and dissociation under equilibrium conditions. 
Therefore, we addressed the question regarding which of 
these processes was responsible for the presumed in- 
creased affinity of receptor dimers. Ligand association 
analysis showed that inhibition of receptor dimerization 
by using either MAb K27 or domain 4-deleted receptor 
did not result in significant changes in kon values. By con- 
trast, the extremely slow rate of ligand dissociation from 
Kit was dramatically increased by MAb K27 (ko, = 2.7 
x 10-5/s; Figure 7B). Similarly, the dimerization-defective 
mutant released the ligand at a comparable rate (ko, = 
2.8 x 10-~/s), and this effect was enhanced when the 
overall rate of SCF dissociation was increased by the addi- 
tion of unlabeled ligand to the dissociation medium (Figure 
7D). In conclusion, the observed reduction in SCF binding 
affinity upon inhibition of dimer formation by two indepen- 
dent methods was due to an increase in the rate of ligand 
dissociation. 
Discussion 
Ligands of receptor tyrosine kinases are either monomeric 
(e.g., EGF) or dimeric (e.g., PDGF), and, therefore, they 
are expected to be monovalent or bivalent. Nevertheless, 
both types of ligands induce rapid dimerization of their 
respective receptors, suggesting that bivalency is not es- 
sential for forming receptor dimers. This paradigm was 
supported by our observation that human and mouse Kit 
proteins form heterodimers upon binding of the human- 
specific ligand (Lev et al., 1992b). On the basis of this and 
other lines of evidence, we proposed a sequential model 
that attributes receptor dimerization to a putative intrinsic 
receptor site, which undergoes conformational "opening" 
consequent o ligand binding. Recent studies appear to 
support this model. Monovalent interactions of PDGF with 
its receptor (Herren et al., 1993) and a monomeric CSF-1 
molecule (Krautwald and Baccarini, 1993) were found to 
be biologically active. The observation that a soluble Kit 
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Figure 6. The Effect of Inhibition of Receptor Dimerization on SCF- 
Induced DNA Synthesis 
(A) The SCF-dependent human myeloid TF1 cells were incubated with 
SCF (5 ng/ml) in the presence of increasing concentrations ofMAb 
K44 (closed squares), MAb K27 (circles), or MAb K45 (open squares). 
The incorporation of[3H-methyl]thymidine into acid-insoluble macro- 
molecules was determined after 44 hr by using a 4 hr pulse with the 
radiolabeled precursor. The results are presented as the percentages 
of inhibition of thymidine incorporation i the presence of SCF. Each 
data point is the average of a duplicate determination. 
(B) Murine fibroblasts that expressed either wild-type Kit (squares) or 
a domain 4-deletion mutant (circles) were grown in 24-well culture 
dishes. Different concentrations ofSCF were added after 2 days of 
serum starvation, and incubation was continued for 43 hr, followed 
by a 5 hr pulse with [3H-methyl]thymidine (5 ~.Ci/well). Acid alcohol 
precipitable radioactivity was determined intriplicates. Scale bars indi- 
cate standard eviations. 
protein that lacked the C-terminal two immunoglobulin-like 
domains lost its ability to undergo ligand-induced imer- 
ization (Figure 3) further supported the notion that ligand 
bivalency is insufficient for receptor dimerization. The abil- 
ity of the fourth immunoglobulin-like domain to confer li- 
gand-dependent dimerization to both soluble (Figure 3A) 
and transmembrane (Figure 3B) Kit proteins and epitope 
mapping of a dimerization-inhibitory MAb to this domain 
(Figure 2B) identified immunoglobulin domain 4 as the 
intrinsic receptor dimerization site. It is interesting that 
in the related receptor for CSF-1, namely Fms, several 
oncogenic mutations that activate tyrosine phosphoryla- 
tion by stabilizing receptor dimers were mapped to the 
fourth domain of this receptor (Carlberg and Rohrschneider, 
1994). In both Fms and Kit, the fourth immunoglobulin-like 
domains lack the characteristic intradomain S-S bond. 
Receptor Dimerization Is Driven by the Rate 
of Ligand Dissociation 
The availability of a dimerization-inhibitory MAb and a di- 
merization-defective Kitenabled us to directly address the 
currently open causative relationships between ligand 
binding and receptor dimerization. Monomeric Kit proteins 
displayed reduced affinity to SCF under equilibrium condi- 
tions when their conversion to dimers was prevented by 
a MAb or by deletion of the intrinsic dimerization site (Fig- 
ure 7). In addition, we noted an apparent limited decrease 
in receptor numbers. Unlike MAb-treated Kit, domain 
4-deleted receptors clearly exhibited acurvilinear Scatch- 
ard plot. This negative curvature is characteristic of other 
types of receptors (e.g., EGF receptor), and it may suggest 
that SCF binding to monomers is negatively cooperative. 
Otherwise, it may reflect receptor heterogeneity, which 
does not exist in the presence of MAb K27. Independent 
of the exact interpretation, the results of the ligand binding 
analyses strongly suggest that dimerization of Kit is driven 
by the higher ligand affinity of receptor dimers as com- 
pared with that of receptor monomers. Further analyses 
(Figure 7B and 7D) identified the rate of ligand release 
from the receptor as the cause of the affinity differences. 
Evidently, forcing receptor monomerization accelerated 
the rate of SCF dissociation. An almost inevitable model 
would then attribute ligand-induced imerization of Kit to 
an equilibrium between receptor monomers and dimers, 
of which the former forms predominate. Apparently, SCF 
associates at the same rate with both monomeric and di- 
meric forms, but it is retained by receptor dimers for a 
significantly longer time. This probably translates into 
shifting the equilibrium toward receptor dimers. The valid- 
ity of this model and its relevance to other growth factor 
receptors is supported by several lines of evidence. For 
example, it has been previously shown that an oncogenic 
mutation that constitutively maintains dimers of the Neu/ 
ErbB2 receptor (Weiner et al., 1989) increased ligand affin- 
ity by slowing the rate of ligand dissociation (Ben-Levy et 
al., 1992). 
Structural Features of the Fourth 
Immunoglobulin-like Domain of Kit 
The observation that the dimerization site of Kit is limited 
to a single immunoglobulin-like domain is in contrast with 
the noncontiguous and extended nature of the SCF- 
binding site (Blechman et al., 1993; Lev et al., 1993). Since 
no higher order oligomers of Kit were observed and be- 
cause we mapped only one dimerization site on Kit, it 
seems likely that this site is monovalent and is symmetri- 
cally located on the dimerized molecules. These principles 
prevail in the dimeric structure of immunoglobulin-related 
molecules (Williams and Barclay, 1988). The fourth do- 
main, however, is unique in that it lacks the intradomain 
disulfide bond. Nondisulfide-linked immunoglobulin-like 
domains exist in several immunoglobulin-related mole- 
cules, such as the major histocompatibility complex anti- 
gens, ~2-microglobulin-associated antigens, domain 3 of 
the CD4 molecule (Brady et al., 1993), and domain 1 of 
the CD2 molecule (Jones et al., t 992). The corresponding 
portions of these molecules often display higher structural 
flexibility, which in the case of Kit may permit its regulability 
by ligand binding. 
Despite the absence of the hallmark two cysteine resi- 
dues, the seven I} strands of Fc domains are readily recog- 
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Figure 7. AnalysesofSCFBindingto Kitinthe 
Absence of Receptor Dimerization 
(A) The effect of a dimerization-inhibitory MAb 
on ligand binding. Murine fibroblasts (approxi- 
mately 1 x 10 s cells) that overexpressed the 
human Kit protein were incubated with increas- 
ing concentrations of radiolabeled human SCF 
in the presence of 10 l~g/ml MAb K49 (squares) 
or MAb K27 (circles). Following 3 hr at 4°C, 
the cell monolayers were extensively washed, 
and the remaining radioactivity was deter- 
mined. The results are presented as saturation 
curves (insets) or as Scatchard plots. Each 
data point represents the average of a dupli- 
cate determination. Nonspecific ligand bind- 
ing, which was determined in the presence of 
a 100-fold excess of unlabeled SCF, was sub- 
tracted from the total amount of cell-bound 
SCF. 
(B) Dissociation kinetics. Radiolabeled SCF (50 
ng/ml) was incubated for 3 hr at 4°Cwith 1 x 
105 cells that overexpressed human Kit. Follow- 
ing a brief washing step at 4°C, the cells were 
incubated with the following MAbs (10 p.g/ml): 
K49 (squares), K27 (circles), or K44 (triangles). The amount of ligand that was dissociated from the cells was determined a  various time intervals, 
and nonspecifically bound radioactivity was subtracted from it.The data were analyzed according to a previously described method (Berkers et 
al., 1991). Accordingly, Btis the amount of ligand that remained bound at time t of dissociation, and Bo is the amount of ligand that was bound 
before dissociation was allowed. Each data point represents he average of a duplicate determination. 
(C and D) Analyses of ligand binding to a dimerization-defective receptor. Monolayers of murine fibroblasts that expressed either a wild-type Kit 
protein (squares) or a domain 4-deletion mutant (circles) were analyzed by using radiolabeled SCF exactly as described n (A) and (B), respectively. 
Shown are Scatchard plots (C) together with the corresponding saturation curves (insets) and dissociation curves (D). The latter analysis was 
performed in the absence (closed symbols) or presence (open symbols) of unlabeled SCF (100 ng/ml). Each data point is the average of a duplicate 
determination. 
lin-like domain. Specifically, strands B, C, and F display 
hydrophobic residues in alternating positions and other 
anchoring amino acids, while strands A and G, which do 
not contain conserved residues, are harder to identify. 
These I~ strands are separated by six loops, three of which 
contain potential asparagine-linked glycosylation sites. 
Remarkably, several canonical amino acids, including a 
tryptophan residue (numbered 358 in the human Kit) and 
an upstream proline residue in the B-C loop, match the 
consensus of the C1 set of immunoglobulin-related do- 
mains. Overall, the primary structure best matches the 
requirements of the C2 set and to a lesser extent those 
of the C1 set. Since no crystal structures are available for 
proteins that belong to the C2 set, we based our structural 
model on the structures of the constant domains, CH2 and 
CH3, of the human Fc fragment (Deisenhofer, 1981). This 
was followed by several steps of energy minimization, 
which yielded a typical 13 sheet structure with a hydropho- 
bic interior. The predicted intersheet distance was larger 
than that in the Fc and Fv domains because the conserved 
cysteine residues were replaced by hydrophobic side 
chains. This result is supported by the crystal structure of 
domain 3 of CD4 (Brady et al,, 1993). The energy-minimized 
model of domain 4 was superimposed by best molecular 
fit onto the two domains forming the CH3 dimer of the 
human Fc fragment. The resulting model dimer is depicted 
in Figure 8. The predicted interface between the domains 
has a mixed hydrophobic and electrostatic nature. Four 
pairs of hydrophobic side chains (shown in blue in Figure 
8) are found in the core of the interface. This patch is 
flanked on both sides by 10 charged or polar residues 
Figure 8. Predicted Structure of a Dimer of Isolated Fourth Domains 
of Kit 
The ribbon diagram of the peptide backbones of the domains is viewed 
from the C-terminal side. To discriminate between he monomers, each 
is shown with a different color (gray or green). Only the peptide back- 
bone is shown, except for the interdomain interface, at which atoms 
of the side residues are shown in blue (hydrophobic residues that 
comprise a hydrophobic patch) or pink (hydrophilic residues that flank 
the hydrophobic patch). The N- and C-termini of each monomer are 
indicated. The locations of the three pairs of asparagine residues, 
which are presumably linked to sugar residues, are shown in red. Note 
that each monomer has a characteristic core, which is delineated by 
I~ sheets. 
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(shown in pink in F igure 8). An important  outcome of this 
model  structure is the est imat ion of its stabi l i ty in compar i -  
son to other  d imers  of  immunog lobu l in  domains .  Due to 
the presence  of  severa l  salt br idges  and a larger  hydropho-  
bic core,  monomer -monomer  interact ions in ord inary  im- 
munog lobu l in  mo lecu les  are s igni f icant ly  more  stable than 
the predicted d imer  of domain  4. Remarkab ly ,  domain  4 
d imers  are held together  predominant ly  by electrostat ic  
rather than by hydrophob ic  interact ions,  and s ince these 
can be rep laced  by monomer -so lvent  interact ions,  the ex- 
pected stabi l i ty of  domain  4 d imers  is low in compar ison  
to the const i tut ive d imers  of  immunog lobu l in  molecules.  
At present,  the exact  mode of  induct ion of  receptor  di- 
mers  remains  open.  Another  unanswered  quest ion relates 
to the molecu lar  mechan ism that couples  l igand binding to 
d imer  format ion.  Possibly,  in t ramolecu lar  conformat iona l  
changes  and interact ions with the fifth immunoglobu l in -  
l ike domain ,  the role of  which is present ly  unknown,  are 
involved.  Neverthe less ,  s imi lar  intrinsic s i tes may exist  in 
other  receptor  tyros ine k inases.  Moreover ,  receptors  that 
conta in immunoglobu l in - l i ke  b locks  in their  ec todomains  
outnumber  receptors  with o ther  structural  motifs. There-  
fore, the observat ions  descr ibed  here for domain  4 of  Kit 
may be re levant  to other  growth factor  receptors .  
Experimental Procedures 
Materials and Antibodies 
Radioactive materials were purchased from Amersham Corp. Poly- 
clonal antibodies to human Kit/SCF receptor were raised in rabbits 
that were injected with a recombinant Kit-X protein or with a 14 amino 
acid synthetic peptide that corresponds to the C-terminal tail of the 
human Kit protein (Ab 212). MAbs directed against the extracellular 
domain of human Kit were generated and purified as has been pre- 
viously described (Blechman et al., 1993). A rabbit antibody to PI3K 
was prepared against a synthetic peptide containing the COOH- 
terminal 15 amino acids of human p85~ (Lev et al., 1992a). Radiolabel- 
ing of SCF, biosynthetic labeling, Western blotting, and the composi- 
tions of buffered solutions were as previously described (Blechman 
et al., 1993). 
Construction and Expression of Kit 1-2-3-4 
To express Kit 1-2-3-4, we used a previously described plasmid that 
contained the cDNA of the full-length ectodomain of Kit (Lev et al., 
1992c). A 265 bp SphI-Clal segment that encoded the fifth immuno- 
globulin-like domain was removed the Clal site was treated with 
Klenow DNA polymerase, and the Sphl site was treated with T4 DNA 
polymerase. The resulting blunt ends of the plasmid were religated. 
This placed four additional codons that code for arginine, leucine, 
valine, and isoleucine downstream of the codon of asparagine residue 
423 of human c-kit, followed by an in-frame stop codon. A 1304 bp 
BamHI-Xbal fragment was then isolated from the plasmid and was 
inserted into the pcDNAI-NEO expression vector (Invitrogene). Trans- 
fectants were selected in medium containing gentamycin (0.8 mg/ml), 
and single-cell colonies were selected. 
Construction and Expression of Domain 4-Deleted Kit Protein 
To construct a cDNA that directs expression of a Kit protein lacking 
the fourth immunoglobuiin-like domain (A4), we used a previously de- 
scribed mutant of c-kit (Lev et al., 1993) in which a Kpnl site was 
introduced into the cDNA portion that codes for the region between 
domains 3 and 4 (at nucleotide number 910). The mutant gene, in a 
Bluescript vector, was cut with Kpnl and Bglll (nucleotide position 
2240) to yield a 1330 bp fragment. Two DNA fragments were then 
amplified by using polymerase chain reaction (PCR) and the isolated 
KpnI-Bglll fragment: The first amplified piece of DNA was 78 bp long 
and corresponded to residues 910-988 of c-kit. The following oligonu- 
cleotides were used as primers: 5'-GGTGGTACCGCAAATGTC-3' and 
5'-GGCAGCATTGACGTCCGTAGTGGTTATCATGGG-3'. The second 
amplified DNA fragment was 1026 bp long and corresponded to nucle- 
otides 1214-2240. The sequences of the oligonucleotide primers were 
as follows: 5'-GACGTCAATGCTGCCATAGC-3' and 5'-CACAGATC- 
TCC I I I I GTCGG-3'. Both fragments were purified from agarose gels, 
denatured, annealed, and filled in with Klenow enzyme. The region 
of complementarity is indicated by an underline in the corresponding 
sequences of the oligonucleotide primers. The annealed and extended 
DNA fragment was used as a template for PCR amplification by using 
the following oligonucleotide primers: 5'-GGTGGTACCGCAAATGTC- 
3' and 5'-CACAGATCTCCTITTGTCGG-3'. The amplified DNA frag- 
ment was cleaved with Bglll and Kpnl and was inserted into the original 
c-kit-containing Bluescript plasmid. The integrity of the open reading 
frame was confirmed by nucleotide sequencing, and the mutated DNA 
was introduced into a mammalian expression vector. Murine NIH 3T3 
fibroblasts were cotransfected with the constructed expression vector 
and pSV2neo. Single-cell clones were selected by growth in gentami- 
cin-containing (0.8 mg/ml) medium, and overexpressors were selected 
by using a binding assay with radiolabeled SCF. 
Thymidine Incorporation Assays 
Murine fibroblasts that overexpress either wild-type Kit or a domain 
4-deleted mutant (A4) were grown to 80% confluence in 24-well dishes 
that were coated with 10 p~g/ml of human plasma fibronectin in phos- 
phate-buffered saline (PBS). Cells were starved for 48 hr in DME me- 
dium containing 0.1% of FCS, and then SCF was added. The cells 
were further incubated for 48 hr at 22°C. [3H-methyl]thymidine (5 llCi/ 
well) was added for the last 5 hr of incubation, and acidic alcohol- 
precipitable radioactivity was determined. Each data point is the aver- 
age of a triplicate determination. Alternatively, TF1 cells were grown 
as a suspension culture in RPMI 1640 medium supplemented with 
10% FCS and 2 ng/ml of recombinant human GM-CSF until the ceils 
reached a concentration of 1 x 108 per milliliter. Growth factor depriva- 
tion was achieved by washing the cells twice in RPMI 1640 medium. 
Cells were seeded at 10,000/well in 96-well plates and preincubated 
for 2 hr with or without the indicated concentrations of various MAbs, 
and then human SCF (5 ng/ml) was added. Following 48 hr of incuba- 
tion, [3H-methyl]thymidine was added (1 ~Ci/well) for the last 4 hr. 
Cells were harvested using a cell harvester (PHD, Cambridge Tech), 
and radioactivity was determined by liquid scintillation counting. 
Assay of Intracellular Ca 2. Mobilization 
Cells were plated on 25 mm coverslips at a density of 8 x 104 cells 
per coverslip. Following 48 hr of culturing in DME medium with 5% 
FCS, the medium was replaced with the same medium containing 
0.5% FCS for 16 hr. The cells were maintained in the starvation me- 
dium without phenol red for an additional 2 hr before loading them 
with 2 ~M Fura2-AM for 1 hr. Excess dye was removed by washing 
the monolayers three times (2 ml each time) with the same medium, 
which had no serum. The coverslips were then mounted in a 25 mm 
chamber and were treated with SCF or FCS at 22°C as indicated. 
The fluorescence at wavelength 510 nm was monitored by using exci- 
tations at 340 nm and 380 nm (MacCumber et al., 1990). The ratio 
between the images at 340 nm and 380 nm was obtained with a compu- 
terized video imaging system (Biological Detection Systems), and the 
relative intracellular Ca b levels were determined. 
Covalent Cross-Linking of SCF to Kit Proteins 
Confluent monolayers of Kit-expressing cells were grown in 65 mm 
diameter plates. The cells were first washed with PBS and then were 
incubated with or without different MAbs in the presence of radiola- 
beled SCF (20 ng of human SCF per milliliter). After 90 rain at 4°C, 
the plates were transferred to 22°C and either 1-ethyl-3-(3-dimethyl- 
aminopropyl)-carbodiimide (EDAC) (15 raM), disuccinimidyl suberate 
(DSS), or bis(sulphosuccinimidyl) suberate (BS 3, Pierce Biochemical) 
was added to a final concentration of 0.5 raM. The cross-linking reac- 
tion was terminated by extensive washing with PBS, followed by 5 
min of incubation with PBS containing 150 mM glycine-HCI buffered 
at pH 7.5. To examine SCF binding to soluble Kit proteins, the affinity- 
purified proteins were incubated in PBS together with 1251-SCF (100 
ng/ml, 1 x 105 cpm/ng) in the presence of unlabeled SCF (1 p.g) or 
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transforming rowth factor (~ (TGF0q 0.5 p.g). The total reaction volume 
was 0.06 ml. After 4 hr at 22°C, the proteins were subjected to covalent 
cross-linking by adding DSS to 0.5 mM final concentration, and the 
reaction was allowed to continue for an additional 40 rain at 22°C. 
Gel sample buffer was then added, and the reaction was terminated 
by boiling and SDS-PAGE. 
Nondenaturing Polyacrylamide Gel Analysis 
Determination of molecular weights using nondenaturing polyacryi- 
amide gel was carried out as previously described (Amster-Choder 
and Wright, 1992). Kit-X and Kit 1-2-3 proteins that were affinity puri~fied 
by using a MAb to Kit were incubated with radiolabeled SCF in 0:02 
ml of 10 mM Tris-HCI (pH 8.3). Following 2 hr at 22°C, gel sample 
buffer was added (10 mM Tris [pH 6.7], 16% glycerol, 0.04°/0 bromo- 
phenol blue). The mixtures were analyzed on native gels contaiging 
50,6%, 7%, 8%, 8.5%, and 9% acrylamide side by side with standard 
markers (Pharmacia). Electrophoresis was stopped when the dye 
reached the bottom of the gel. The molecular size markers were re- 
vealed by Coomassie blue staining, and the ligand-complexed Kit pro- 
teins were revealed by autoradiography. 
SCF Binding Analysis 
Ligand binding analyses were performed as described (Blechman et 
al., 1993). Ligand association was analyzed by incubation of cell mono- 
layers with radiolabeled SCF (30 ng/ml) in 0.2 ml of binding buffer at 
various time intervals on ice. The monolayers were then [apidly 
washed twice with 1 ml of ice-cold binding buffer and dissolved in 
0.1 N NaOH plus 0.1% SDS, and the radioactivity was determined. 
Duplicate determinations were performed. The nonspecific binding 
that was determined in the presence of a 100-fold excess of unlabeled 
SCF was subtracted, and the association data were analyzed by deter- 
mination of the amount of ligand bound at full saturation (B=). The 
ratio of ligand bound at time t (Bt) to B= was then calculated and 
described as a function of time. For ligand dissociation analysis, cell 
monolayers were allowed to bind radiolabeled SCF (30 ng/ml) for 2 
hr on ice. After a rapid wash with binding buffer, the cells were incu- 
bated for various periods of time with 0.25 ml of binding buffer, with 
or without unlabeled SCF or certain MAbs. The amount of cell-bound 
ligand at the end of the ligand dissociation experiment was determined 
after washing twice with PBS. Duplicate determinations were per- 
formed, and the nonspecific binding was separately quantitated for 
each time point. 
Model Building of Immunoglobulin-like Domain 4 of Kit 
Model building was preceded by alignment of the amino acid se- 
quences of human domain 4 with domains CH2 and CH3 of human 
Fc fragment (Deisenhofer, 1981). An initial model was built in analogy 
to the CH2 domain (Protein Data Bank entry 1FC1). Residues were 
replaced using the interactive graphics program FRODO (Jones, 
1978). The initial model was subjected to several steps of energy mini- 
mization using the program ENCAD (Levitt, 1983). The positions of 
all Ca atoms were initially restrained, and loop regions were subjected 
to 50,000 steps of dynamics at 300K (at one femtosecond per step 
and 50 ps on the whole) with intermittent energy minimizations. The 
sheet framework residues were kept fixed at this stage, The torsion 
angles of several residues at the ends of the ~ sheets deviated from 
values dictated by the Ramachandran plot (Ramachandran and Sas- 
siekharan, 1968). In a subsequent dynamics and minimization run (50 
ps, 300K), these residues were free to move together with the residues 
of the loops. This resulted in considerable improvement in their geome- 
try without disrupting the ~ sheet framework. To construct a model of 
a dimer of domain 4, the energy-minimized model of this domain was 
superimposed by best molecular fit onto the two domains forming 
the CH3 dimer in the human Fc fragment. Only the Ca atoms of the 
conserved cysteine and tryptophan residues and the amino acids that 
flank them at both sides were used to determine the transformation 
matrix and vector. The resulting calculated energy of domain 4 dimers 
was -1536 kcal/mol, whereas the calculated energy of the CH3 dimer 
was -1598 kcal/mol. 
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